Power Law company profile

United Imaging Healthcare

Biotech & Life Sciences · Jing'an District, China · Founded 2011 · IPO 2022 Decacorn

United Imaging Healthcare develops and manufactures medical equipment and solutions

Valuation

$11B

Market cap · May/2026

Revenue

$1.42B

Latest reported FY

EBITDA

$397M

Latest reported FY

Featured in Decacorn$10B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

6 investors on United Imaging Healthcare's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 6 investors entered at this stage

CICC

CITIC Securities

SDIC Fund Management Company

SDIC Fund Management

CMB International

China Life Insurance

Global footprint

Where United Imaging Healthcare has talent and traffic

AI talent share

0.1% of workforce is AI talent
(3 of 2,451 staff)

Core AI30.12%

Other AI00%

Non-AI workforce2,44899.88%

Workforce by country

49 countries with
team presence

🇨🇳 China59.6%

🇺🇸 United States11.6%

🇮🇳 India7.4%

🇲🇾 Malaysia1.7%

🇬🇧 United Kingdom1.7%

Top 5 of 49 shown

Patent intelligence

$659M patent portfolio · 7,761 active families

Estimated portfolio value

$659M

5.8% of market cap · 10.2× the top peer Axonics ($65M)

7,761 active patent families

Where United Imaging Healthcare innovates Mechanical engineeringRadiologyComputer equipmentMedical physicsPhysics

Where United Imaging Healthcare concentrates vs peers

Each axis is a top-10 topic across United Imaging Healthcare and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

United Imaging Healthcare's 2 investments and acquisitions.

Every disclosed deal where United Imaging Healthcare appeared as a backer or acquirer, 2024–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

2 deals across United Imaging Healthcare's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount

By stageCount

By periodCount

01 · Deployment strategy vs peers

Where United Imaging Healthcare deploys vs peers

Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

Compare against

02 · Portfolio market map

United Imaging Healthcare's portfolio, mapped.

Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

Stage

Period

2 of 2 deals

Market sentiment

What the market is saying about United Imaging Healthcare

An AI-synthesized read of the highest-engagement posts about United Imaging Healthcare on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See United Imaging Healthcare on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles